Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validation of the AIMIGo 12 Lead ECG Synthesis Software for Arrhythmia Detection: A Prospective Multicenter Pivotal Study

NCT06123130 is registered in ClinicalTrials.gov with HeartBeam, Inc. as lead sponsor.

NCT NCT06123130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06123130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validation of the AIMIGo 12 Lead ECG Synthesis Software for Arrhythmia Detection: A Prospective Multicenter Pivotal Study
Lead sponsor
HeartBeam, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 13, 2024
Completion date
June 20, 2024
Enrollment
198 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, atrial fibrillation, atrial flutter, bradycardia, tachycardia